Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
Chapter 3. Research Methodology
3.1. Introduction
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
Chapter 4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Macroeconomic Indicators
Chapter 5. Market Factor Analysis
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. Investment Feasibility Analysis
Chapter 6. Global Pharmacy Benefit Management Services Market, by Service
6.1. Introduction
6.2. Retail Pharmacy Services
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3. Specialty Pharmacy Services
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.4. Benefit Plan Design and Consultation
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5. Drug Formulary Management
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.6. Others
Chapter 7. Global Pharmacy Benefit Management Services Market, by End User
7.1. Introduction
7.2. Healthcare Providers
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3. Employers
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.4. Drug Manufacturers
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.5. Others
Chapter 8. Global Pharmacy Benefit Management Services Market, by Region
8.1. Introduction
8.2. Americas
8.2.1. North America
8.2.1.1. US
8.2.1.2. Canada
8.2.2. Latin America
8.3. Europe
8.3.1. Western Europe
8.3.1.1. Germany
8.3.1.2. France
8.3.1.3. Italy
8.3.1.4. Spain
8.3.1.5. UK
8.3.1.6. Rest of Western Europe
8.3.2. Eastern Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Middle East & Africa
8.5.1. Middle East
8.5.2. Africa
Chapter 9. Company Landscape
9.1. Introduction
9.2. Market Share Analysis
9.3. Key Developments & Strategies
Chapter 10. Company Profiles
10.1. abarca health LLC.
10.1.1. Company Overview
10.1.2. Product Overview
10.1.3. Financial Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. CVS Health
10.2.1. Company Overview
10.2.2. Product Overview
10.2.3. Financial Overview
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Express Scripts
10.3.1. Company Overview
10.3.2. Product Overview
10.3.3. Financial Overview
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Humana Pharmacy Solutions
10.4.1. Company Overview
10.4.2. Product Overview
10.4.3. Financial Overview
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Magellan Rx Management
10.5.1. Company Overview
10.5.2. Product Overview
10.5.3. Financial Overview
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. McKesson Corporation
10.6.1. Company Overview
10.6.2. Product Overview
10.6.3. Financial Overview
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Medimpact Healthcare
10.7.1. Company Overview
10.7.2. Product Overview
10.7.3. Financial Overview
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. MeridianRx
10.8.1. Company Overview
10.8.2. Product Overview
10.8.3. Financial Overview
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. OptumRx (UnitedHealth)
10.9.1. Company Overview
10.9.2. Product Overview
10.9.3. Financial Overview
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Prime Therapeutics
10.10.1. Company Overview
10.10.2. Product Overview
10.10.3. Financial Overview
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Sea Rainbow
10.11.1. Company Overview
10.11.2. Product Overview
10.11.3. Financial Overview
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. Vidalink
10.12.1. Company Overview
10.12.2. Product Overview
10.12.3. Financial Overview
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
10.13. Others
10.14. .
Chapter 11. MRFR Conclusion
11.1. Key Findings
11.1.1. From CEO’s Viewpoint
11.1.2. Unmet Needs of the Market
11.2. Key Companies to Watch
11.3. Predictions for the Pharmacy Benefit Management Services Industry
Chapter 12. Appendix
LIST OF TABLES
Table 1. Global Pharmacy Benefit Management Services Market Synopsis, 2020–2027
Table 2. Global Pharmacy Benefit Management Services Market Estimates and Forecast, 2020–2027 (USD Million)
Table 3. Global Pharmacy Benefit Management Services Market, by Region, 2020–2027 (USD Million)
Table 4. Global Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 5. Global Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
Table 6. North America: Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 7. North America: Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
Table 8. US: Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 9. US: Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
Table 10. Canada: Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 11. Canada: Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
Table 12. Latin America: Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 13. Latin America: Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
Table 14. Europe: Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 15. Europe: Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
Table 16. Western Europe: Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 17. Western Europe: Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
Table 18. Eastern Europe: Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 19. Eastern Europe: Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
Table 20. Asia-Pacific: Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 21. Asia-Pacific: Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
Table 22. Middle East & Africa: Pharmacy Benefit Management Services Market, by Service, 2020–2027 (USD Million)
Table 23. Middle East & Africa: Pharmacy Benefit Management Services Market, by End User, 2020–2027 (USD Million)
LIST OF FIGURES
Figure 1. Research Process
Figure 2. Segmentation for Global Pharmacy Benefit Management Services Market
Figure 3. Segmentation Market Dynamics for Global Pharmacy Benefit Management Services Market
Figure 4. Global Pharmacy Benefit Management Services Market Share, by Service, 2020
Figure 5. Global Pharmacy Benefit Management Services Market Share, by End User, 2020
Figure 6. Global Pharmacy Benefit Management Services Market Share, by Region, 2020
Figure 7. North America: Pharmacy Benefit Management Services Market Share, by Country, 2020
Figure 8. Europe: Pharmacy Benefit Management Services Market Share, by Country, 2020
Figure 9. Asia-Pacific: Pharmacy Benefit Management Services Market Share, by Country, 2020
Figure 10. Middle East & Africa: Pharmacy Benefit Management Services Market Share, by Country, 2020
Figure 11. Global Pharmacy Benefit Management Services Market: Company Share Analysis, 2020 (%)
Figure 12. Abarca health LLC.: Key Financials
Figure 13. Abarca health LLC.: Segmental Revenue
Figure 14. Abarca health LLC.: Geographical Revenue
Figure 15. CVS Health: Key Financials
Figure 16. CVS Health: Segmental Revenue
Figure 17. CVS Health: Geographical Revenue
Figure 18. Express Scripts: Key Financials
Figure 19. Express Scripts: Segmental Revenue
Figure 20. Express Scripts: Geographical Revenue
Figure 21. Humana Pharmacy Solutions: Key Financials
Figure 22. Humana Pharmacy Solutions: Segmental Revenue
Figure 23. Humana Pharmacy Solutions: Geographical Revenue
Figure 24. Magellan Rx Management: Key Financials
Figure 25. Magellan Rx Management: Segmental Revenue
Figure 26. Magellan Rx Management: Geographical Revenue
Figure 27. McKesson Corporation: Key Financials
Figure 28. McKesson Corporation: Segmental Revenue
Figure 29. McKesson Corporation: Geographical Revenue
Figure 30. Medimpact Healthcare: Key Financials
Figure 31. Medimpact Healthcare: Segmental Revenue
Figure 32. Medimpact Healthcare: Geographical Revenue
Figure 33. MeridianRx: Key Financials
Figure 34. MeridianRx: Segmental Revenue
Figure 35. MeridianRx: Geographical Revenue
Figure 36. OptumRx (UnitedHealth): Key Financials
Figure 37. OptumRx (UnitedHealth): Segmental Revenue
Figure 38. OptumRx (UnitedHealth): Geographical Revenue
Figure 39. Prime Therapeutics: Key Financials
Figure 40. Prime Therapeutics: Segmental Revenue
Figure 41. Prime Therapeutics: Geographical Revenue
Figure 42. Sea Rainbow: Key Financials
Figure 43. Sea Rainbow: Segmental Revenue
Figure 44. Sea Rainbow: Geographical Revenue
Figure 45. Vidalink: Key Financials
Figure 46. Vidalink: Segmental Revenue
Figure 47. Vidalink: Geographical Revenue